TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Histology findings with transmission electron microscopy (TEM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histology findings with optic microscopy (OM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histology findings with immunohistochemistry (IHQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to SARS-nCov-2 test negativization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion in lower extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuromodulation activity (motor unit potential)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Matthias test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiota profiles of fecal samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Toe Walking Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Caloric Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycemic load consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cost changes
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Brain activation and connectivity response to serotonergic stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain electrophysiological activity electroencephalography (EEG) during visual stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain electrophysiological activity electroencephalography (EEG) during auditory stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Receipt of Perinatal Care Components
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sensitivity, specificity, positive and negative likelihood ratio, positive and negative predicted value of recording definite AF episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of device related (serious) adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebral Blood Flow Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral Tissue Oxygenisation Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stanford Acute Stress Reaction Questionnaire (SASRQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical Evaluation Questionnaire (CEQ)-CALM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Harrell's concordance index (C-index)
Endpoint domain: Mortality/survival
Primary endpoint: Rate of major adverse cardiac and cerebrovascular events (MACCE)
Endpoint domain: Adverse events/effects
Primary endpoint: AUC0-t, AUC0-inf, AUC0-24h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swelling Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microembolic Signals (MES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tibialis Anterior Pressure Pain Threshold (PPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the participant's quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in caregiver's quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients diagnosed with placenta accreta spectrum disorder
Endpoint domain: Mortality/survival
Primary endpoint: Evolution in the knowledge about the patient's condition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Evolution in the adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: GMT of anti- SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 4-fold rise of anti- SARS-CoV-2 neutralizing antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Endotracheal tube position inside the trachea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Critical Thinking Disposition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Communication Skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Healthy Living Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Food intake in grams during a standard meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food intake in kcal during a standard meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSMA Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adult sensory profile test Raw score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Generalized Anxiety Disorder 7-Item Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Performance of LumiraDx POC CRP assay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of communication methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of FreeStyle Libre 2 Flash Glucose Monitoring System
Endpoint domain: Adverse events/effects
Primary endpoint: Hba1c change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Management of pediatric anaphylaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Oro-tracheal intubation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Verbal learning and memory performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Impact of Incontinence on Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in clinical symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatocellular carcinoma (HCC) screening rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HCC screening performance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Freedom from Index Procedure Related Major Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Target Vessel Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of angina-related events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 1-minute sit-to-stand (1-MSTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intraoperative detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental occlusal measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Molar and canine relationships
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: History of orthodontic treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Success rate of culturing primary cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Representation to the original tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of the combined laser and HITS treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the combined laser and HITS treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Shoulder Pain Functionality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparative Reader Percentage Agreement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Blinded Reader Percentage Agreement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: AUCinf of Atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUCinf of Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUCinf of Levonorgestrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUCinf of Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in blood flow velocities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain free time after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of Xpert MTB/RIF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of referrals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: number of screenings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Resident physician Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PVPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre to Post Change in Sustained attention (Response time variability)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre to Post Change in Sustained attention (commission errors)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre to Post Change in Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pre to Post Change in anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pre to Post Change in emotional regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Manual Ability Classification System (MACS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spasticity level evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Compliance with laxative intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Impact of enuresis on life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of functional decline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Protein profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: True-negative, true-positive, false-negative and false-positive rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-months CR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance of LAM antigen test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Voice analysis indicators (residue, aspiration)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of B7-H3-CAR T cells
Endpoint domain: Adverse events/effects
Primary endpoint: Number of New Diagnoses of Cardiac Amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Internal consistency
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: ITGA4 gene expression pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Healthy parenting behavior measurement #1
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Complete resection (R0) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of thrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Survival to heart transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with complete wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diagnostic performance of ArtiQ.Spiro
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of newly discovered rare, high penetrance germline variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of newly discovered structural genomic variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of newly discovered common, low penetrance germline variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of newly discovered somatic mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Radiographic Bone density assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complication due to gallstones
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Achieving Clinical Remission Based on the CDAI at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Exhibiting an Endoscopic Response Based on Simple Endoscopic Score for CD (SES-CD) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Deep Trunk Flexibility test (DTF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Hand Grip test (HG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Stand Test (TST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The 30-s Sit-Up (SUP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The 6-Min Walk Test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of detection of MB2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour pad test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: cLIA GMTs to 9 vaccine types at one month post last dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cLIA GMTs to 9 vaccine types up to 60 months post last dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cLIA seropositivity percentages to 9 vaccine types
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Temporal changes in quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Procedure safety
Endpoint domain: Adverse events/effects
Primary endpoint: Patients' and clinicians' knowledge on PSA test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' and clinicians' opinions on PSA test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients who participated in shared-decision making
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in subject clinical status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Analog Scale (VAS) Score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Prevalence of pain in verbal patients with RASopathies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Pain in no-communicating patients with RASopathies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention at 6-months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention at 12-months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Treatment Satisfaction at 6-months: rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Myotonometric Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Isokinetic Balance Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Improvement rate of glabellar lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: satisfactory completion of body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurement of resting metabolic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: measurement of body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in hemoglobin, hematocrit, and reticulocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Monthly Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal analogue scale for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LU patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and proportion of treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in % body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Grade ≥3 infusion-related adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Grade ≥4 non-hematologic adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Grade ≥3 pneumonitis, uveitis
Endpoint domain: Adverse events/effects
Primary endpoint: Grade ≥3 toxicities that are attributed to TSA-T
Endpoint domain: Adverse events/effects
Primary endpoint: Any unexpected toxicity of grade ≥3 attributed to the infusion of TSA-T
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability of CDK-004
Endpoint domain: Adverse events/effects
Primary endpoint: Vmax variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Time in Range [70 to 180 mg/dL]
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Numerical Pain Rating Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain medication consumed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of radiation-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Overall pain score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain at treated site
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bioindicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bubble inclinometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apathy and ruthlessness (CU traits)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve (AUC) of 40 mg/kg PZA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right and left hand grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum isometric muscle strength of the quadriceps femoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lean body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of suspicious cytology (Bethesda III-VI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antagonist enamel wear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Brief Pain Inventory (BPI) pain severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Stanford Sleepiness Scale (SSS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: change in PROMIS Neuro-QOL score for cognitive function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post prandial glycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Post prandial insulemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Global Quality of Recovery (QoR-40) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of Masimo RAD-GT Temperature Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macular Pigment Optical Density - heterochromatic flicker photometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Macular Pigment Optical Density - haidinger's brushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Premenstrual Syndrome Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes